Barriers to clinical trial enrollment

Part I of a two-part series

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

According to the National Cancer Institute (NCI), 1,735,350 people were newly diagnosed with cancer in 2018. Of those, 65% are expected to achieve remission from their cancer 1.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe

YOU MAY BE INTERESTED IN

How’s this for a paradox: The better cancer centers become at keeping patients alive, the more expensive cancer care becomes. This brutal tradeoff hits harder in rural areas, where the cancer burden is higher and the investigator and clinical trial representation is lower.
Daniel Wall, BSc
Research administrator, Marshfield Clinic
Stephanie Engelien, RN, MSN
Oncology research nurse, Marshfield Clinic
Adedayo A. Onitilo, MD, PhD, MSCR, FACP
Director, Oncology/Hematology
and Radiation Oncology Service Line; Department chair, Oncology/Hematology, Marshfield Clinic

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login